Literature DB >> 26951400

Insomnia is Associated with Cortical Hyperarousal as Early as Adolescence.

Julio Fernandez-Mendoza1, Yun Li1, Alexandros N Vgontzas1, Jidong Fang1, Jordan Gaines1, Susan L Calhoun1, Duanping Liao2, Edward O Bixler1.   

Abstract

STUDY
OBJECTIVES: To examine whether insomnia is associated with spectral electroencephalographic (EEG) dynamics in the beta (15-35Hz) range during sleep in an adolescent general population sample.
METHODS: A case-control sample of 44 adolescents from the Penn State Child Cohort underwent a 9-h polysomnography, clinical history and physical examination. We examined low-beta (15-25 Hz) and high-beta (25-35 Hz) relative power at central EEG derivations during sleep onset latency (SOL), sleep onset (SO), non-rapid eye movement (NREM) sleep, and wake after sleep onset (WASO).
RESULTS: Compared to controls (n = 21), individuals with insomnia (n = 23) showed increased SOL and WASO and decreased sleep duration and efficiency, while no differences in sleep architecture were found. Insomniacs showed increased low-beta and high-beta relative power during SOL, SO, and NREM sleep as compared to controls. High-beta relative power was greater during all sleep and wake states in insomniacs with short sleep duration as compared to individuals with insomnia with normal sleep duration.
CONCLUSIONS: Adolescent insomnia is associated with increased beta EEG power during sleep, which suggests that cortical hyperarousal is present in individuals with insomnia as early as adolescence. Interestingly, cortical hyperarousal is greatest in individuals with insomnia with short sleep duration and may explain the sleep complaints of those with normal sleep duration. Disturbed cortical networks may be a shared mechanism putting individuals with insomnia at risk of psychiatric disorders.
© 2016 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  EEG; adolescence; beta; hyperarousal; insomnia

Mesh:

Year:  2016        PMID: 26951400      PMCID: PMC4835300          DOI: 10.5665/sleep.5746

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  48 in total

1.  The EEG of the sleep onset period in insomnia: a discriminant analysis.

Authors:  H Merica; J M Gaillard
Journal:  Physiol Behav       Date:  1992-08

2.  Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion.

Authors:  A N Vgontzas; S Pejovic; E Zoumakis; H M Lin; E O Bixler; M Basta; J Fang; A Sarrigiannidis; G P Chrousos
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-29       Impact factor: 4.310

3.  REM and NREM power spectral analysis on two consecutive nights in psychophysiological and paradoxical insomnia sufferers.

Authors:  Geneviève St-Jean; Isabelle Turcotte; Alexandra D Pérusse; Célyne H Bastien
Journal:  Int J Psychophysiol       Date:  2013-06-13       Impact factor: 2.997

Review 4.  Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder.

Authors:  Alexandros N Vgontzas; Julio Fernandez-Mendoza; Duanping Liao; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2013-02-16       Impact factor: 11.609

5.  Beta/Gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls.

Authors:  M L Perlis; M T Smith; P J Andrews; H Orff; D E Giles
Journal:  Sleep       Date:  2001-02-01       Impact factor: 5.849

6.  Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort.

Authors:  Julio Fernandez-Mendoza; Alexandros N Vgontzas; Duanping Liao; Michele L Shaffer; Antonio Vela-Bueno; Maria Basta; Edward O Bixler
Journal:  Hypertension       Date:  2012-08-14       Impact factor: 10.190

7.  Chronic insomnia and activity of the stress system: a preliminary study.

Authors:  A N Vgontzas; C Tsigos; E O Bixler; C A Stratakis; K Zachman; A Kales; A Vela-Bueno; G P Chrousos
Journal:  J Psychosom Res       Date:  1998-07       Impact factor: 3.006

8.  EEG spectral analysis in primary insomnia: NREM period effects and sex differences.

Authors:  Daniel J Buysse; Anne Germain; Martica L Hall; Douglas E Moul; Eric A Nofzinger; Amy Begley; Cindy L Ehlers; Wesley Thompson; David J Kupfer
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

Review 9.  Diagnosis and management of childhood obstructive sleep apnea syndrome.

Authors:  Carole L Marcus; Lee Jay Brooks; Kari A Draper; David Gozal; Ann Carol Halbower; Jacqueline Jones; Michael S Schechter; Sally Davidson Ward; Stephen Howard Sheldon; Richard N Shiffman; Christopher Lehmann; Karen Spruyt
Journal:  Pediatrics       Date:  2012-08-27       Impact factor: 7.124

Review 10.  The hyperarousal model of insomnia: a review of the concept and its evidence.

Authors:  Dieter Riemann; Kai Spiegelhalder; Bernd Feige; Ulrich Voderholzer; Mathias Berger; Michael Perlis; Christoph Nissen
Journal:  Sleep Med Rev       Date:  2009-05-28       Impact factor: 11.609

View more
  31 in total

1.  DSM-5 Insomnia and Short Sleep: Comorbidity Landscape and Racial Disparities.

Authors:  David A Kalmbach; Vivek Pillai; J Todd Arnedt; Christopher L Drake
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

2.  Insomnia symptoms with objective short sleep duration are associated with systemic inflammation in adolescents.

Authors:  Julio Fernandez-Mendoza; Joshua H Baker; Alexandros N Vgontzas; Jordan Gaines; Duanping Liao; Edward O Bixler
Journal:  Brain Behav Immun       Date:  2016-12-30       Impact factor: 7.217

Review 3.  The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders.

Authors:  David A Kalmbach; Jason R Anderson; Christopher L Drake
Journal:  J Sleep Res       Date:  2018-05-24       Impact factor: 3.981

4.  Insomnia symptoms and short sleep predict anxiety and worry in response to stress exposure: a prospective cohort study of medical interns.

Authors:  David A Kalmbach; James L Abelson; J Todd Arnedt; Zhuo Zhao; Jessica R Schubert; Srijan Sen
Journal:  Sleep Med       Date:  2018-12-14       Impact factor: 3.492

Review 5.  Insomnia disorder in adolescence: Diagnosis, impact, and treatment.

Authors:  Massimiliano de Zambotti; Aimee Goldstone; Ian M Colrain; Fiona C Baker
Journal:  Sleep Med Rev       Date:  2017-07-01       Impact factor: 11.609

6.  Childhood high-frequency EEG activity during sleep is associated with incident insomnia symptoms in adolescence.

Authors:  Julio Fernandez-Mendoza; Yun Li; Jidong Fang; Susan L Calhoun; Alexandros N Vgontzas; Duanping Liao; Edward O Bixler
Journal:  J Child Psychol Psychiatry       Date:  2018-07-10       Impact factor: 8.982

7.  Clusters of Insomnia Disorder: An Exploratory Cluster Analysis of Objective Sleep Parameters Reveals Differences in Neurocognitive Functioning, Quantitative EEG, and Heart Rate Variability.

Authors:  Christopher B Miller; Delwyn J Bartlett; Anna E Mullins; Kirsty L Dodds; Christopher J Gordon; Simon D Kyle; Jong Won Kim; Angela L D'Rozario; Rico S C Lee; Maria Comas; Nathaniel S Marshall; Brendon J Yee; Colin A Espie; Ronald R Grunstein
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

8.  Natural history of insomnia symptoms in the transition from childhood to adolescence: population rates, health disparities, and risk factors.

Authors:  Julio Fernandez-Mendoza; Elizaveta Bourchtein; Susan Calhoun; Kristina Puzino; Cynthia K Snyder; Fan He; Alexandros N Vgontzas; Duanping Liao; Edward Bixler
Journal:  Sleep       Date:  2021-03-12       Impact factor: 5.849

9.  Behavioral Strategies, Including Exercise, for Addressing Insomnia.

Authors:  Rachel R Markwald; Imran Iftikhar; Shawn D Youngstedt
Journal:  ACSMs Health Fit J       Date:  2018 Mar-Apr       Impact factor: 1.364

10.  The falling asleep process in adolescents.

Authors:  Massimiliano de Zambotti; Aimee Goldstone; Mohamad Forouzanfar; Harold Javitz; Stephanie Claudatos; Ian M Colrain; Fiona C Baker
Journal:  Sleep       Date:  2020-06-15       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.